What are the properties of CBCA in supplements?
The CBCA has not yet been classified as a component of any supplement we recommend, however, if you know of any specific that should be put on our list, please feel welcome to submit your proposition (contact us). We will gladly consider adding it to our catalogue.
CBCA - References & External links
CBCA (Cannabichromenic Acid)
TBS Ingredient ID (TBSI ID): | ISEAAE20 | ||
---|---|---|---|
Name | |||
CBCA
| |||
Chemical Formula: | |||
C22H30O4 | |||
Molecular Formula: | |||
Classification Type | Identifier | ||
PubChem CID: U.S. National Library of Medicine (PubChem) | 3084339 | ||
InChI Key: International Chemical Identifier hash (InChIKey) computed from chemical structure using the International Union of Pure and Applied Chemistry (IUPAC) standard | HRHJHXJQMNWQTF-UHFFFAOYSA-N | ||
CAS: A proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS) | 20408-52-0 | ||
NIST: The National Institute of Standards and Technology (NIST) | 20408-52-0 | ||
ChemIDplus: United States National Library of Medicine - TOXNET (Toxicology Data Network). | 20408-52-0 | ||
DSSTox Substance ID: United States Environmental Protection Agency (EPA). | DTXSID80942575 | ||
UNII: FDA Substance Registration System - Unique Ingredient Identifier | NNW8UMP980 |
The references to scientific articles about CBCA are not meant to imply that any products treat, cure, or diagnose any disease or human condition. We encourage our audience to do their own research beyond the resources we have provided so your decision is as educated as possible.
- The general properties of CBCA:
- STONE, Nicole L.; et al. A systematic review of minor phytocannabinoids with promising neuroprotective potential. British Journal of Pharmacology, 2020, 177.19: 4330-4352. PMID:32608035